Diagnosis of Early-Stage Idiopathic Parkinson's Disease Using High-Resolution Quantitative Susceptibility Mapping Combined with Histogram Analysis in the Substantia Nigra at 3 T
暂无分享,去创建一个
Eung Yeop Kim | Jongho Lee | Hyeong-Geol Shin | Yoonho Nam | Young Hee Sung | Young Noh | E. Kim | Jongho Lee | Y. Nam | Y. Sung | Y. Noh | Hyeong-Geol Shin
[1] Xuemei Huang,et al. Quantitative susceptibility mapping of the midbrain in Parkinson's disease , 2016, Movement disorders : official journal of the Movement Disorder Society.
[2] Tony F. Chan,et al. Active contours without edges , 2001, IEEE Trans. Image Process..
[3] Wei Cao,et al. A method for estimating and removing streaking artifacts in quantitative susceptibility mapping , 2015, NeuroImage.
[4] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[5] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[6] Matthew J. Betts,et al. The whole-brain pattern of magnetic susceptibility perturbations in Parkinson’s disease , 2017, Brain : a journal of neurology.
[7] R. Bowtell,et al. Visualization of nigrosome 1 and its loss in PD , 2013, Neurology.
[8] Dong-Hyun Kim,et al. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map‐weighted imaging (SMWI) , 2017, Journal of magnetic resonance imaging : JMRI.
[9] J. Lee,et al. Nigrosome 1 Detection at 3T MRI for the Diagnosis of Early-Stage Idiopathic Parkinson Disease: Assessment of Diagnostic Accuracy and Agreement on Imaging Asymmetry and Clinical Laterality , 2015, American Journal of Neuroradiology.
[10] Xue Xiao,et al. Integrated Laplacian‐based phase unwrapping and background phase removal for quantitative susceptibility mapping , 2014, NMR in biomedicine.
[11] Michael Schocke,et al. Dorsolateral nigral hyperintensity on 3.0T susceptibility‐weighted imaging in neurodegenerative Parkinsonism , 2015, Movement disorders : official journal of the Movement Disorder Society.
[12] Dorothee P. Auer,et al. The ‘Swallow Tail’ Appearance of the Healthy Nigrosome – A New Accurate Test of Parkinson's Disease: A Case-Control and Retrospective Cross-Sectional MRI Study at 3T , 2014, PloS one.
[13] Ji Young Yun,et al. Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With 123I‐FP‐CIT SPECT , 2016, Movement disorders : official journal of the Movement Disorder Society.
[14] P-Y Lin,et al. Quantitative Susceptibility Mapping of Human Brain at 3T: A Multisite Reproducibility Study , 2015, American Journal of Neuroradiology.
[15] Pascal Spincemaille,et al. Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors , 2015, Journal of magnetic resonance imaging : JMRI.
[16] E. Kim,et al. Drug-induced Parkinsonism versus Idiopathic Parkinson Disease: Utility of Nigrosome 1 with 3-T Imaging. , 2016, Radiology.
[17] Nian Wang,et al. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping , 2017, NMR in biomedicine.
[18] M. Tosetti,et al. Nigral involvement in atypical parkinsonisms: evidence from a pilot study with ultra-high field MRI , 2016, Journal of Neural Transmission.
[19] E Mark Haacke,et al. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2. , 2015, Magnetic resonance imaging.
[20] N. Wang,et al. Using ‘swallow-tail’ sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson’s disease: A susceptibility-weighted imaging study , 2017, European Radiology.
[21] Kemin Chen,et al. Region‐specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping , 2015, Human brain mapping.
[22] T. Simuni,et al. Can loss of the swallow tail sign help distinguish between Parkinson Disease and the Parkinson-Plus syndromes? , 2017, Clinical imaging.
[23] M. Tosetti,et al. MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease. , 2014, Radiology.
[24] Y Wang,et al. Usefulness of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson Disease , 2015, American Journal of Neuroradiology.
[25] C Strand,et al. 9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease , 2016, NeuroImage: Clinical.
[26] Ferdinand Schweser,et al. Quantitative Susceptibility Mapping in Parkinson's Disease , 2016, PloS one.
[27] Y Wang,et al. Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility Mapping , 2016, American Journal of Neuroradiology.
[28] A. Graybiel,et al. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.
[29] M. Fukunaga,et al. Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure , 2010, Proceedings of the National Academy of Sciences.
[30] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[31] M. Tosetti,et al. Comparison of 3T and 7T Susceptibility-Weighted Angiography of the Substantia Nigra in Diagnosing Parkinson Disease , 2015, American Journal of Neuroradiology.